Cargando…

Selective Insulin Receptor Modulators (SIRM): A New Class of Antidiabetes Drugs?

Detalles Bibliográficos
Autores principales:	Vigneri, Riccardo, Squatrito, Sebastiano, Frittitta, Lucia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331756/ https://www.ncbi.nlm.nih.gov/pubmed/22517652 http://dx.doi.org/10.2337/db12-0192

Ejemplares similares

Integrated insulin pump therapy with continuous glucose monitoring for improved adherence: technology update
por: Tumminia, Andrea, et al.
Publicado: (2015)

Secular Trends in the Prevalence of Overweight and Obesity in Sicilian Schoolchildren Aged 11–13 Years During the Last Decade
por: Parrino, Cristina, et al.
Publicado: (2012)

Insulin degludec in the first trimester of pregnancy: Report of two cases
por: Milluzzo, Agostino, et al.
Publicado: (2017)

Women in radiology: the SIRM believes in equal opportunity
por: Giovagnoni, Andrea, et al.
Publicado: (2022)

Pharmacogenetics of new classes of antidiabetic drugs
por: Kadrić, Selma Imamović, et al.
Publicado: (2021)

Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors
por: Pellegriti, Gabriella, et al.
Publicado: (2013)

Prevalence and Clinical Characteristics of Children and Adolescents with Metabolically Healthy Obesity: Role of Insulin Sensitivity
por: Vinciguerra, Federica, et al.
Publicado: (2020)

Announcing the novel class of GABA–A receptor selective positive allosteric modulator antidepressants
por: Fasipe, Olumuyiwa John, et al.
Publicado: (2020)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Lo, Chris Wai Hang, et al.
Publicado: (2021)

Prescriptive Analytics-Based SIRM Model for Predicting Covid-19 Outbreak
por: Al Qundus, Jamal, et al.
Publicado: (2023)

New therapeutic strategy for Alzheimer's disease using antidiabetes agents
por: Yokono, Koichi
Publicado: (2013)

Sodium–glucose cotransporter 2 inhibitors: A drug with antidiabetic and cardioprotective properties
por: Li, Hung‐Yuan
Publicado: (2020)

Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance
por: Su, Wen-Jun, et al.
Publicado: (2017)

Insulin receptor signaling and glucagon-like peptide 1 effects on pancreatic beta cells
por: Caporarello, Nunzia, et al.
Publicado: (2017)

Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
por: Cheung, BMY, et al.
Publicado: (2020)

Athero-protective actions of two oral antidiabetic drugs: Suppression of inflammation and oxidative stress
por: Chen, Kan
Publicado: (2012)

Challenges in modulating insulin receptor signalling as a therapeutic strategy for cancer
por: Srinivas, Priya, et al.
Publicado: (2018)

SIRM-SIN-AIOM: appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations—consensus statements from Italian College of Radiology (SIRM), Italian College of Nephrology (SIN) and Italian Association of Medical Oncology (AIOM)
por: Orlacchio, Antonio, et al.
Publicado: (2022)

Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM
por: Pediconi, Federica, et al.
Publicado: (2020)

Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis
por: Fei, Yue, et al.
Publicado: (2019)

Gliptins: A New Class of Oral Antidiabetic Agents
por: Seshadri, K. G., et al.
Publicado: (2009)

How many oral antidiabetic drugs before insulin?
por: Kelwade, Jayant, et al.
Publicado: (2017)

Impact of oral antidiabetic agents on bone metabolism
por: Paul, Thomas V., et al.
Publicado: (2015)

Insulin receptor trafficking steers insulin action
por: Hausmann, Simone, et al.
Publicado: (2016)

Glucocorticoid Receptor Antagonism as a New “Remedy” for Insulin Resistance—Not There Yet!
por: Varlamov, Elena V, et al.
Publicado: (2021)

New Antidiabetes Agent Targeting Both Mitochondrial Uncoupling and Pyruvate Catabolism: Two Birds With One Stone
por: Rui, Liangyou
Publicado: (2019)

Insulin Receptor Isoforms Differently Regulate Cell Proliferation and Apoptosis in the Ligand-Occupied and Unoccupied State
por: Massimino, Michele, et al.
Publicado: (2021)

Selection and Adaptation of Cells Expressing Major Histocompatibility Complex Class I–specific Receptors of the Natural Killer Complex
por: Bendelac, Albert
Publicado: (1997)

Advances in breast cancer treatment and prevention: preclinical studies on aromatase inhibitors and new selective estrogen receptor modulators (SERMs)
por: Schiff, Rachel, et al.
Publicado: (2003)

Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM)
por: Fan, Teresa WM, et al.
Publicado: (2009)

The Antidiabetic Functions of the Pancreas and Successful Isolation of the Antidiabetic Hormone Insulin
Publicado: (1924)

Prevention of breast cancer using selective oestrogen receptor modulators (SERMs)
por: Powles, Trevor J
Publicado: (2006)

The Current Status of New Antidiabetic Drugs
por: Pemminati, Sudhakar, et al.
Publicado: (2016)

Insulin Analogs and Cancer
por: Sciacca, Laura, et al.
Publicado: (2012)

Insulin Receptor Isoforms in Cancer
por: Vella, Veronica, et al.
Publicado: (2018)

Non-Insulin Novel Antidiabetic Drugs Mechanisms in the Pathogenesis of COVID-19
por: Salmen, Teodor, et al.
Publicado: (2022)

Optimizing weight control in diabetes: antidiabetic drug selection
por: Kalra, S, et al.
Publicado: (2010)

Antidiabetic Actions of an Estrogen Receptor β Selective Agonist
por: Alonso-Magdalena, Paloma, et al.
Publicado: (2013)

Insulin: a wonder drug in the critically ill?
por: Johan Groeneveld, AB, et al.
Publicado: (2002)

Type 2 Diabetes Mellitus and Alzheimer’s Disease: Role of Insulin Signalling and Therapeutic Implications
por: Tumminia, Andrea, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gpk0e547luuupbrkspep71n2s0